Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Requip, Adartrel, Ropinirol
Ropinirole is a non-ergot dopamine agonist primarily used in the treatment of Parkinson's disease and restless legs syndrome (RLS). It works by mimicking the effects of dopamine in the brain, helping to control movement and reduce the symptoms of these conditions. Ropinirole belongs to a class of medications called dopamine agonists.
For treating Parkinson's disease and restless legs syndrome.
May cause sudden sleep onset.
Outcome:
Increased ropinirole levels
Mechanism:
Inhibition of CYP1A2 metabolism
Outcome:
Additive effects, potential for hypotension
Mechanism:
Synergistic effects on dopamine receptors
Outcome:
Reduced ropinirole absorption
Mechanism:
Chelation/binding
Most likely new formulation: extended-release formulation for improved patient compliance (Year: 2025, 60% confidence)
Based on current usage trends and clinical trial data, there is a 70% likelihood of ropinirole remaining a first-line treatment for RLS in the next 5 years.
Dopamine Agonist
Pyrrole derivative